LABORATORIO FARMAC.ERFO (RK7) — Cash Flow Reinvestment Rate
LABORATORIO FARMAC.ERFO (RK7) has a Cash Flow Reinvestment Rate of 1.38x as of December 2023, reinvesting €1.79 Million (capex €1.45 Million plus investments €345.57K) from operating cash flow of €1.30 Million. See RK7 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
LABORATORIO FARMAC.ERFO Cash Flow Reinvestment Rate (2021–2023)
Historical reinvestment intensity for LABORATORIO FARMAC.ERFO across 3 annual periods. For the full cash flow conversion analysis, see LABORATORIO FARMAC.ERFO cash conversion from operations.
Annual Cash Flow Reinvestment Rate for LABORATORIO FARMAC.ERFO (2021–2023)
Year-by-year capital reinvestment analysis for LABORATORIO FARMAC.ERFO. See RK7 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 1.38x | €1.79 Million | €1.30 Million | €1.45 Million | ▼ -44.4% |
| 2022 | 2.49x | €1.89 Million | €761.80K | €1.18 Million | ▲ +806.2% |
| 2021 | 0.27x | €623.55K | €2.27 Million | €242.84K | — |